MARCO, upregulated in response to pathogenic challenge2, has been implicated in defence against pathogens in the lung3, phagocytosis and clearance of tumor cells 4, internalisation of exosomes 5, and has been touted as a potential target in anti-cancer immunotherapy 6. The gene discussed is MARCO; the disease is neoplasm.